AMLXNasdaq United States
Market cap
$2.537 B
$22.82 -5.66%
Close of 7 Aug 2026
Revenue
$0.00
#3658 by revenue
Earnings
-$144.7M
Loss-making
Shares outstanding
111,423,048
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Amylyx Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.